Senior Director, Toxicology at AbbVie and Head of Toxicology at Cerevel Therapeutics @ AbbVie / Cerevel Therapeutics, LLC (May 2020 - January 2025)
Head of Nonclinical Safety @ (August 2017 - March 2020)
Toxicology Project Leader and Regulatory Safety Lead @ (December 2012 - August 2017)
Head of Biochemical Toxicology and Discovery Safety Lead @ (December 2009 - December 2012)
Investigator III : Head of Early Biochemical toxicology and Discovery Safety Lead @ (September 2006 - December 2009)
Principal Scientist: Head of Off-target kinase safety and Discovery Safety Lead @ (September 2003 - September 2006)
Senior Scientist @ (February 2002 - August 2003)
Senior Research Scientist @ (September 2000 - October 2001)
Madhu Dabt Education
Harvard Medical School
Postdoctoral Fellow (Molecular Plarmacology)
Visva-Bharati University
B. S. & M. S.
University of Oxford
Postdoctoral Fellow (Molecular Pharmacology)
Tata Institute of Fundamental Research, Mumbai
Ph. D. (Molecular Pharmacology)
Madhu Dabt Summary
Madhu Dabt, based in Boston, MA, US, is currently a Head of Toxicology at Gate Bioscience. Madhu Dabt brings experience from previous roles at Project Toxicology Consultants, Boston (PTCB), AbbVie / Cerevel Therapeutics, LLC, FORMA Therapeutics, Inc. and AstraZeneca. Madhu Dabt holds a Postdoctoral Fellow in Molecular Plarmacology @ Harvard Medical School. Madhu Dabt has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Madhu Dabt?
Find contact details for 700 million professionals.